Madrigal Pharmaceuticals Inc (MDGL)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$449.88
Buy
$451.23
$-15.93 (-3.41%)
Prices updated at 13 Oct 2026, 19:57 EDT
| Prices minimum 15 mins delay
Prices in USD
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver fa ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $468.65 - $448.77 | |
| $615.00 - $393.61 | |
| - | |
| 10,793.32m | |
| - | |
| - | |
| 160,232 | |
| 20.61 | |
| 335,097.56 | |
| 1.30 | |
| 22.84m | |
| US5588681057 | |
| -12.85 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.